The JOHNSON’S brand, known for iconic products like baby shampoos and lotions , is owned by Kenvue Inc.. Kenvue is a standalone, publicly traded company that was spun off from Johnson & Johnson in August 2023.

Detailed Company Description of Kenvue

Overview:
Kenvue is the world’s largest pure-play consumer health company by sales, generating over $15 billion in annual revenue. It focuses exclusively on everyday care products, distinct from Johnson & Johnson’s current focus on pharmaceuticals and medical technology.

Headquarters:
The company is headquartered in Summit, New Jersey, United States.

Purpose and Philosophy:
Kenvue’s stated purpose is to “Realize the Extraordinary Power of Everyday Care”. The company operates on the belief that everyday self-care rituals contribute significantly to overall well-being.

Brand Portfolio:
In addition to the JOHNSON’S baby line, Kenvue’s extensive portfolio of science-backed brands includes:

Pain Management:
Tylenol (acetaminophen)

Skin Health & Beauty:
Neutrogena, Aveeno

Oral Care:
Listerine

Wound Care:
BAND-AID Brand Adhesive Bandages

Other:
Benadryl, Zyrtec

Market Position and Operations:
Kenvue operates globally, touching the lives of over a billion consumers worldwide. It employs approximately 22,000 people and competes in the consumer packaged goods industry. The company operates with a strong emphasis on scientific research and professional recommendations for its products.

Recent Developments

Acquisition:
In November 2025, Kimberly-Clark announced its intent to acquire Kenvue, a deal expected to close in the second half of 2026, which would further expand its portfolio of consumer brands.

Product Formulation:
The company has transitioned its baby powder products from talc-based formulas to cornstarch-based ones globally, a commercial decision made amid ongoing litigation and changing consumer sentiment regarding talc safety.